Oura Buys Counsel Health for $625 Million to Put a Physician Behind the Ring

Good morning, HealthTech insiders. A smart ring company agreed to buy a doctor's office on Tuesday, and a search company launched a back office for hospitals. Oura will pay $625 million in cash for Counsel Health, the AI-native primary care service it has run inside its app since earlier this year, so a change in your sleep or temperature can now end in a physician visit and a prescription without leaving the ring's app. A few hours earlier, Google Cloud put Gemini for healthcare into U.S. preview, an agent that reads from Epic and Oracle Health, checks Medicare coverage rules and assembles prior authorization packets.

Put those next to Charta Health's $55 million round to run one AI chart review for both payers and providers, and a single question links all three stories: who owns the context? Oura owns continuous biometrics, Google wants to own the layer that stitches records to coverage, and Charta wants to own the version of the chart both sides agree on before a claim goes out. Whoever holds the context gets to decide what happens next, and that is where the margin is moving.

In today's Signal:

• Oura agrees to acquire Counsel Health for $625 million in cash (announced November 10), alongside a record quarter: revenue up 153% year over year to $533 million and $87 million of adjusted EBITDA, both preliminary and unaudited.

• Google Cloud launches Gemini for healthcare in U.S. preview (November 10), with read-only Epic and Oracle Health connectors, CMS coverage lookups and model choice across Google, Anthropic and OpenAI; launch customers include HCA Healthcare, Northwell Health, Highmark Health and Optum.

• Charta Health raises a $55 million Series B led by Insight Partners (November 10) and launches Charta for Payers, after growing revenue 10x in 12 months.

• Plus: Virtuoso Surgical discloses the first De Novo in a new FDA robot class, smartwatch ECG AI splits between Apple and Samsung watches at AHA, and Nimbus doses its first SIK2 inhibitor in humans.

In partnership with

The AI Work Handbook That Cuts Your Workday in Half

The 8-hour workday is becoming a 4-hour workday for people who know how to use AI.

Everyone else is still catching up.

This AI work playbook shows you exactly how to cut your work hours in half using AI.

Sign up for Superhuman AI and get:

• 50+ step-by-step AI tutorials to cut your workload in half, covering every part of your workday, from emails to strategy, used by 1M+ professionals at Google, Microsoft, and NASA

• Superhuman AI newsletter (4 min daily) so you keep discovering new AI tools and skills to stay ahead in your career, the playbook is just the start

Claim your AI playbook

WEARABLES
1. Oura Buys Counsel Health for $625 Million to Put a Physician Behind the Ring

On November 10, Oura announced a $625 million cash deal to acquire Counsel Health, an AI-powered primary care company combining medical AI with board-certified physicians. Oura members can already access Counsel through their health insights and escalate to physicians for diagnoses, lab orders and prescriptions. The acquisition brings these services in-house and is expected to close by year-end.

The details:

• Usage: Over half of Counsel users in Oura Labs shared ring data with physicians; more than 90% said it improved care. Physician consultations earned 4.6/5 ratings, with doctor access priced at $29.

• Financials: Oura reported Q4 revenue of $533 million (+153%) and $87 million in adjusted EBITDA. Full-year revenue reached $1.75 billion (+92%). The company has over six million members. Figures are preliminary and unaudited.

• Leadership: CEO Tom Hale described the deal as a step toward a “24-7 doctor in your pocket.” Counsel CEO Muthu Alagappan emphasized physician oversight. Counsel will continue serving health plans, health systems and employers, including non-Oura users.

The Signal: Wearables have struggled to turn health insights into clinical care. Acquiring Counsel closes that gap, expanding Oura’s model beyond hardware and subscriptions into medical services, while reaching non-ring users through enterprise contracts. For health systems, the bigger question is whether consumer platforms become the new entry point to primary care and whether payers will reimburse data-triggered visits.

AGENTIC PLATFORMS
2. Google Cloud Launches Gemini for Healthcare, an Agent That Reads the EHR and the Coverage Rules

On November 10, Google Cloud launched Gemini for healthcare in U.S. preview, connecting EHRs, billing systems, clinical guidelines and CMS data to automate multi-step workflows with human oversight. Early customers include Blue Cross Blue Shield of Massachusetts, HCA Healthcare, Optum, Northwell Health and Stanford School of Medicine.The details:

• Connectors: Read-only access to Epic and Oracle Health, with NextGen in development. Integrations include CMS coverage data, NPI, ICD-10, RxNorm and IMO Health, plus Optum, Waystar, GoodRx and other revenue-cycle tools.

• Capabilities: Patient timelines, pre-visit preparation, prior authorization and appeal drafts, payer policy reviews and out-of-pocket estimates. ASCO is adding a Guidelines Assistant.

• Commercials: Available through Gemini Enterprise Standard and Plus with per-seat or usage-based pricing. Supports Google, Anthropic and OpenAI models, with cost-based routing. Google says customer data is not used to train its foundation models.

The Signal: The strategic tell is read-only. Google is not trying to replace Epic; it is trying to own the layer above every system of record, where a prior auth packet or a benefits answer gets assembled from five sources. That squeezes single-workflow point solutions, because a health system with one governed agent and a marketplace of connectors has less reason to buy a separate tool per task. Open model choice also signals that the moat is the connectors and governance, not the model.

REVENUE CYCLE
3. Charta Health Raises $55 Million to Run One AI Chart Review for Both Payers and Providers

On November 10, Charta Health raised a $55 million Series B led by Insight Partners, bringing total funding to $85 million. The round supports the launch of Charta for Payers, extending its AI-powered chart review technology from providers to insurers.

The details:

• Traction: Revenue grew 10x in 12 months, according to Charta. Customers include American Family Care, Grow Therapy and Pediatric Associates, with AI findings reviewed by humans inside the EHR.

• Payer platform: Six tools covering HCC coding, risk adjustment, coding validation, audits and HEDIS care gaps, targeting Medicare Advantage and ACA plans.

• Leadership: CEO Justin Liu and CTO Scott Morris earned professional coding credentials before building the platform. Charta cites research estimating over $25 billion in hospital claims adjudication costs in 2023, including nearly $18 billion potentially wasted on denials and appeals.

The Signal: Billing AI has become an arms race, with providers optimizing coding and payers automating denials. Charta is betting that a shared AI engine can reduce disputes rather than fuel them, particularly as CMS expands Medicare Advantage audits. If both sides trust the same chart analysis, value shifts from managing denials to preventing them, potentially threatening traditional denial management vendors.

👀 WHAT WE'RE WATCHING NEXT

1. Oura and Counsel after close: We're watching for the close before year end, whether Counsel's $29 physician add-on becomes part of Oura's membership, how many Counsel enterprise contracts with health plans and employers survive the change of owner, and whether the pair's planned work on CMS's ACCESS model produces outcome-based Medicare revenue.

2. Gemini for healthcare beyond preview: We're watching for general availability, the first write-back capability into an EHR, published prior authorization turnaround data from launch customers, and how Epic, Microsoft and the point-solution vendors in Google's own connector list respond.

3. Charta on the payer side: We're watching for the first named health plan customer for Charta for Payers, whether a payer and a provider publicly agree to use the same chart review standard, and whether denial and appeal rates move for Charta's provider customers as CMS's expanded Medicare Advantage audits proceed.

💰 FOLLOW THE MONEY

The deals:

• Oura: $625M cash acquisition of Counsel Health to turn wearable health insights into clinical care, including prescriptions.

• Charta Health: $55M Series B led by Insight Partners to unify chart reviews across providers and payers.

• Zus Health: $33M Series B led by Drive Capital to expand its networked patient records platform, which processed over 110M transactions in August.

• Alterra Labs: $12.5M seed round led by Oak HC/FT to build clinical testing environments that expose AI model failures.

The pattern: Capital is moving toward the infrastructure that makes clinical AI trustworthy. As models become increasingly interchangeable, investors are backing platforms that control patient data, clinical context and model evaluation rather than standalone AI tools.

📆 UPCOMING HEALTHTECH EVENTS

• HLTH USA 2026: November 15 to 18, 2026 · The Venetian Expo, Las Vegas, NV

  Days after Oura's deal and Google's launch, the main U.S. digital health gathering is where health systems, payers and consumer platforms will be asked who owns the front door and the back office.

• VEITHsymposium 2026: November 17 to 21, 2026 · New York, NY

  A major vascular and endovascular meeting, useful for tracking how endoluminal robotics and image-guided navigation move from first authorizations into operating rooms.

• HIMSS27 Global Health Conference & Exhibition: April 5 to 8, 2027 · McCormick Place, Chicago, IL

  The main U.S. health IT buying event of the spring, after the January 2027 CMS prior authorization API deadline, and a likely stage for agent platforms and payer-provider AI.

🛠️ Trending HealthTech AI Tools

• Net Health ambient documentation in WoundExpert. Launched November 10, the AI captures wound care visits directly into structured EHR fields, with clinician review. Net Health reports roughly 50% faster documentation, with Chart Summary and Chart Audit coming next.

• Medable Clinical Oversight Agent. Announced November 10 with Alveus Therapeutics, the AI monitors trial enrollment, retention, data quality and protocol compliance across connected systems, providing evidence-backed recommendations.

• Zus Generated Patient Summaries. AI-powered, source-linked summaries of patient records for visit preparation, care transitions and risk adjustment. Zus reports 39 million evidence citations generated in 2026 to date.

🛠️ Trending HealthTech AI Startups

Alterra Labs: New York startup building simulated clinical environments to test and train AI agents across EHRs, imaging systems and payer workflows. Raised a $12.5M seed led by Oak HC/FT on November 10. Founded by Columbia medical student Akash Kapoor.

Boltz PBC: AI drug discovery company developing models for protein structures and molecular design. On November 10, announced ADMET models trained on Excelra's GOSTAR data and reported promising results across 6 of 10 difficult targets. Led by CEO Gabriele Corso.

Rayca Precision: San Francisco AI drug discovery startup partnering with two U.S. academic cancer centers to develop therapies for high-risk HPV-driven cancers. Announced November 10, with CEO Pouya Behrouzi leading computational discovery.

DECISION INTELLIGENCE

Highlights: Deep Dives & Industry Reports

• The Ring Gets a Doctor: Oura, Counsel and the Race to Close the Loop From Signal to Prescription. What Oura actually bought, how consumer wearables are splitting by mechanism and care model, who pays for a visit that starts with a biometric trend, and the tests that would prove the model.

• The Orchestration Layer: What Gemini for Healthcare Means for Epic, Point Solutions and the Back Office. Why read-only connectors and open model choice matter more than the model, which vendors gain or lose when one governed agent sits above every system, and what CMS's 2027 API deadline changes.

• One Chart, Two Sides: Charta Health and the End of the Coding Arms Race. How AI turned billing into an escalation loop, why Medicare Advantage audits change payer demand, and what has to be true for payers and providers to accept one chart review.

That's it for today!

A ring company buying a care service with its own physicians, a cloud company that reads the chart without writing to it, and a billing startup that sells the same engine to both sides of a claim. None of them is selling a better model. Each is buying or building the context that makes a model's output safe to act on: a member's trended biometrics, a patient's records joined to their coverage rules, a chart both payer and provider agree is true.

That shifts the competitive map. EHR vendors still hold the record, but the action is moving to whoever assembles context across records, devices and policies. If Oura's physicians see your sleep data before your primary care doctor does, if Google's agent builds the prior auth packet your revenue cycle team used to build, and if payers accept Charta's chart reading, which part of your current stack is still the system of record that matters?

See you tomorrow,

Dr. Dereck Mush, MD, MBA

The HealthTech Signal is independently funded. Sponsorships help us invest in better reporting, research, and a stronger newsletter for our readers. Want to reach HealthTech founders & executives while supporting the Signal? Get in touch.

Was this email forwarded to you? Sign up here.